Fengtao Zhou

3.1k total citations · 1 hit paper
66 papers, 2.6k citations indexed

About

Fengtao Zhou is a scholar working on Organic Chemistry, Molecular Biology and Inorganic Chemistry. According to data from OpenAlex, Fengtao Zhou has authored 66 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Organic Chemistry, 23 papers in Molecular Biology and 7 papers in Inorganic Chemistry. Recurrent topics in Fengtao Zhou's work include Protein Degradation and Inhibitors (12 papers), Catalytic C–H Functionalization Methods (11 papers) and Ubiquitin and proteasome pathways (10 papers). Fengtao Zhou is often cited by papers focused on Protein Degradation and Inhibitors (12 papers), Catalytic C–H Functionalization Methods (11 papers) and Ubiquitin and proteasome pathways (10 papers). Fengtao Zhou collaborates with scholars based in China, Thailand and Japan. Fengtao Zhou's co-authors include Qiuyu Zhang, Qian Cai, Panbo Liu, Sai Gao, Ying Huang, Ke Ding, Hepeng Zhang, Yi Wang, Baoliang Zhang and Zijian Guo and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Fengtao Zhou

63 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Conductive Antibacterial Hemostatic Multifunctional Scaffolds Based on Ti₃C₂T_x MXene Nanosheets for Promoting Multidrug-Resistant Bacteria-Infected Wound Healing

2021 319 citations Hua Zheng, Shenqiang Wang et al. profile →

Peers

Countries citing papers authored by Fengtao Zhou

Since Specialization

Citations

This map shows the geographic impact of Fengtao Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengtao Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengtao Zhou more than expected).

Fields of papers citing papers by Fengtao Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengtao Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengtao Zhou. The network helps show where Fengtao Zhou may publish in the future.

Co-authorship network of co-authors of Fengtao Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Fengtao Zhou. A scholar is included among the top collaborators of Fengtao Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengtao Zhou. Fengtao Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The design and synthesis of selective and potent selenium-containing KRASG12D inhibitors 2025 ·European Journal of Medicinal Chemistry ·(unknown), Yayuan Yang, (unknown), Jie Wang, Ping Zhang, Yang Zhou, Jinwei Zhang, Xiaomei Ren, Zhen Wang, Weixue Huang, Zhimin Zhang, Xin Zhang, (unknown), Fengtao Zhou	0
2	Lysosomal EGFR acts as a Rheb-GEF independent of its kinase activity to activate mTORC1 2025 ·Cell Research ·Xiaobo He, Qiuxia Wang, Denghui Wei, (unknown), (unknown), Yuanzhong Wu, (unknown), Zhuo Lin, Bei-Bei Xiao, Qinxue Wu, Zhen Wang, Fengtao Zhou, (unknown), Jingxuan Wang, Run Gong, Ruhua Zhang, Qingling Zhang, Ke Ding, Song Gao, Tiebang Kang	3
3	Study on compressive performance and strength formation mechanism of fully recycled aggregate concrete 2025 ·Construction and Building Materials ·Changqing Deng, Zhihua Shi, (unknown), Fengtao Zhou, (unknown), Feng Gao, Zhi‐Chao Jiang	0
4	Discovery of LHF418 as a new potent SOS1 PROTAC degrader 2024 ·Bioorganic & Medicinal Chemistry ·Huifan Li, (unknown), Yihan Chen, Fengtao Zhou, Xiaomei Ren, (unknown), Jian Wang, Zhen Wang, Weixue Huang	4
5	Discovery of LLC0424 as a Potent and Selective in Vivo NSD2 PROTAC Degrader 2024 ·Journal of Medicinal Chemistry ·(unknown), Abhijit Parolia, Yihan Liu, (unknown), (unknown), Yuanyuan Qiao, Sanjana Eyunni, (unknown), Chungen Li, Yongxing Wang, Fengtao Zhou, Weixue Huang, Xiaomei Ren, Zhen Wang, Arul M. Chinnaiyan, Ke Ding	13
6	Discovery of 5-aminopyrido[2,3-d]pyrimidin-7(8H)-one derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitors 2024 ·European Journal of Medicinal Chemistry ·(unknown), Rong Liu, (unknown), (unknown), Xiaomei Ren, Fengtao Zhou, Jinwei Zhang, Weixue Huang, Zhen Wang, Ke Ding	5
7	Discovery of ZLC491 as a Potent, Selective, and Orally Bioavailable CDK12/13 PROTAC Degrader 2024 ·Journal of Medicinal Chemistry ·Licheng Zhou, (unknown), Yu‐Sun Chang, (unknown), (unknown), (unknown), (unknown), Rahul Mannan, Somnath Mahapatra, Ming Ding, Fengtao Zhou, Weixue Huang, Xiaomei Ren, Jian Xu, (unknown), (unknown), Zhen Wang, Arul M. Chinnaiyan, Ke Ding	8
8	Structure-Based Design of “Head-to-Tail” Macrocyclic PROTACs 2024 ·SHILAP Revista de lepidopterología ·Chungen Li, Yihan Chen, Weixue Huang, (unknown), Sheng-Jie Huang, Yang Zhou, Fengtao Zhou, (unknown), Xiaomei Ren, Jinwei Zhang, Zhen Wang, Ming Ding, Ke Ding	8
9	Discovery of the first selective and potent PROTAC degrader for the pseudokinase TRIB2 2024 ·European Journal of Medicinal Chemistry ·(unknown), Prathibha R. Gajjala, Yihan Liu, (unknown), Manjot Bal, (unknown), Yuanyuan Qiao, Yang Zheng, (unknown), Jinwei Zhang, Weixue Huang, Xiaomei Ren, (unknown), Ke Ding, Arul M. Chinnaiyan, Fengtao Zhou	3
10	Cohort-Individual Cooperative Learning for Multimodal Cancer Survival Analysis 2024 ·IEEE Transactions on Medical Imaging ·Huajun Zhou, Fengtao Zhou, Hao Chen	6
11	Access to 2,4‐Disubstituted Pyrrole‐Based Polymer with Long‐Wavelength and Stimuli‐Responsive Properties via Copper‐Catalyzed [3+2] Polycycloaddition 2024 ·Macromolecular Rapid Communications ·Lingna Wang, Jianbo Zhang, Chunmei Li, Wanbin Dang, (unknown), Junjian Xie, Fengtao Zhou, Qiuyu Zhang	1
12	Discovery of LWY713 as a potent and selective FLT3 PROTAC degrader with in vivo activity against acute myeloid leukemia 2023 ·European Journal of Medicinal Chemistry ·Wenyan Liu, Yu Bai, Licheng Zhou, Jian Jin, Meiying Zhang, Yongxing Wang, (unknown), Weixue Huang, Xiaomei Ren, Nan Ma, Fengtao Zhou, Zhen Wang, Ke Ding	13
13	Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyve 2023 ·Journal of Medicinal Chemistry ·Chungen Li, Yuanyuan Qiao, Xia Jiang, (unknown), Yang Zheng, (unknown), (unknown), Fengtao Zhou, Yang Zhou, Weixue Huang, Xiaomei Ren, Yuzhuo Wang, Zhen Wang, Arul M. Chinnaiyan, Ke Ding	10
14	Discovery of new Lenalidomide derivatives as potent and selective GSPT1 degraders 2023 ·European Journal of Medicinal Chemistry ·(unknown), Xinxin Xu, (unknown), Yongxing Wang, Yang Zhou, Zhen Wang, Zhang Zhang, Fengtao Zhou, Ke Ding	11
15	Discovery of AXL Degraders with Improved Potencies in Triple-Negative Breast Cancer (TNBC) Cells 2023 ·Journal of Medicinal Chemistry ·(unknown), Zhiqiang Song, Yu Bai, Sheng He, Jing Huang, Yongxing Wang, Fengtao Zhou, Weixue Huang, (unknown), Zhen Wang, Zhengchao Tu, Xiaomei Ren, Zhang Zhang, (unknown), Ke Ding	17
16	Discovery of the First Examples of Threonine Tyrosine Kinase PROTAC Degraders 2022 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Jing Huang, (unknown), Minhao Huang, Xiaoyun Lu, Yong Xu, Fengtao Zhou, Zhang Zhang, Ke Ding	20
17	1-Methyl-3-((4-(quinolin-4-yloxy)phenyl)amino)-1H-pyrazole-4-carboxamide derivatives as new rearranged during Transfection (RET) kinase inhibitors capable of suppressing resistant mutants in solvent-front regions 2022 ·European Journal of Medicinal Chemistry ·Yunong Zhang, (unknown), (unknown), (unknown), (unknown), Zhengchao Tu, Xiaomei Ren, Yang Zhou, Zhang Zhang, Zhen Wang, Fengtao Zhou, Ke Ding	10
18	Magnetic porous N-doped carbon composites with adjusted composition and porous microstructure for lightweight microwave absorbers 2020 ·Carbon ·Panbo Liu, (unknown), Sai Gao, Yi Wang, Ying Huang, Fengtao Zhou, Peizhou Liu	126
19	Biodegradable conductive multifunctional branched poly(glycerol-amino acid)-based scaffolds for tumor/infection-impaired skin multimodal therapy 2020 ·Biomaterials ·Li Zhou, Hua Zheng, Shenqiang Wang, Fengtao Zhou, Bo Lei, Qiuyu Zhang	34
20	Recent advances in copper-catalyzed asymmetric coupling reactions 2015 ·Beilstein Journal of Organic Chemistry ·Fengtao Zhou, Qian Cai	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact